03/09/2002
Queen's scientists make breast cancer breakthrough
Scientists at Queen's University Belfast believe they have made a breakthrough in explaining how a single gene can trigger breast cancer.
Researchers at the Queen's say that a fault in the BRCA1 gene can prevent the body's immune system from fighting cancer cells.
Dr Paul Harkin and his colleagues at the university used cutting-edge technology to look at thousands of genes at once to find out which ones are switched on under different circumstances.
After comparing normal cells with cells that had an overactive BRCA1 gene they found that when the gene was faulty the immune system was unable to attack cancer cells.
However, by adding a healthy copy of the BRCA1 gene they were able to restore the observation system.
Commenting on the results, Professor Patrick Johnston, director of the Cancer Research Centre at Queen¹s University in Belfast, said they were beginning to shed light on why some women have such a high risk of developing breast cancer.
He concluded: "Now we can see that the faulty gene also impairs the body's ability to spot cells that are becoming cancerous. This combination of problems may explain the gene's devastating effects."
(MB)
Researchers at the Queen's say that a fault in the BRCA1 gene can prevent the body's immune system from fighting cancer cells.
Dr Paul Harkin and his colleagues at the university used cutting-edge technology to look at thousands of genes at once to find out which ones are switched on under different circumstances.
After comparing normal cells with cells that had an overactive BRCA1 gene they found that when the gene was faulty the immune system was unable to attack cancer cells.
However, by adding a healthy copy of the BRCA1 gene they were able to restore the observation system.
Commenting on the results, Professor Patrick Johnston, director of the Cancer Research Centre at Queen¹s University in Belfast, said they were beginning to shed light on why some women have such a high risk of developing breast cancer.
He concluded: "Now we can see that the faulty gene also impairs the body's ability to spot cells that are becoming cancerous. This combination of problems may explain the gene's devastating effects."
(MB)
Related Northern Ireland News Stories
Click here for the latest headlines.
09 September 2011
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
22 May 2019
NI Cancer Patients May Rise By 60%
The number of new cancer patients in Northern Ireland could rocket by over 60% before 2035 if rigorous action is not taken now, Cancer Focus Northern Ireland has warned.
NI Cancer Patients May Rise By 60%
The number of new cancer patients in Northern Ireland could rocket by over 60% before 2035 if rigorous action is not taken now, Cancer Focus Northern Ireland has warned.
07 November 2008
UCF Targets Cancer Awareness
The signs and symptoms of Northern Ireland's biggest cancer killer are being highlighted by a local charity this week with the Ulster Cancer Foundation (UCF) using national 'Lung Cancer Awareness Month' as a springboard to target local people.
UCF Targets Cancer Awareness
The signs and symptoms of Northern Ireland's biggest cancer killer are being highlighted by a local charity this week with the Ulster Cancer Foundation (UCF) using national 'Lung Cancer Awareness Month' as a springboard to target local people.
29 November 2005
Grant awarded for breast cancer drug research
A leading Queen's researcher has been granted more than £130,000 to fund research that could one day lead to the development of another breast cancer fighting drug that would have the same affect as Herceptin.
Grant awarded for breast cancer drug research
A leading Queen's researcher has been granted more than £130,000 to fund research that could one day lead to the development of another breast cancer fighting drug that would have the same affect as Herceptin.
27 September 2002
'Drastic' surgery is best option against breast cancer says report
A controversial report by Queen's University researchers has said that the removal of the breasts and ovaries offers the best hope for women who have a high-risk cancer gene.
'Drastic' surgery is best option against breast cancer says report
A controversial report by Queen's University researchers has said that the removal of the breasts and ovaries offers the best hope for women who have a high-risk cancer gene.